HTG Molecular Diagnostics competitors

HTG Molecular Diagnostics's competitors include Lineagen, Orig3n, Co-Diagnostics and Precipio
Add company...
HTG Molecular Diagnostics
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.
Lineagen
Lineagen provides genetic evaluation services in autism, developmental delay and other genetic disorders.
Orig3n
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Co-Diagnostics
Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.
Precipio
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.
Founding Date
Founding Date
1997
Founding Date
2002
Founding Date
2014
Founding Date
2013
Founding Date
1997
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Tucson, US HQ
Locations
Salt Lake City, US HQ
Locations
Boston, US HQ
Locations
Sandy, US HQ
Locations
Omaha, US HQ
New Haven, US
Employees
Employees
87
Employees
104
Employees
52
Employees
12
Employees
19
Valuation ($)
Valuation ($)
103.8 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
52.4 m
Valuation ($)
9.7 m
Facebook likes
Facebook likes
N/A
Facebook likes
121 k
Facebook likes
6.3 k
Facebook likes
389
Facebook likes
262
Twitter followers
Twitter followers
220
Twitter followers
3.6 k
Twitter followers
14.1 k
Twitter followers
378
Twitter followers
177

Financial

Revenue (est.)
Revenue (est.)
$14.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$7.7k (FY, 2017)
Revenue (est.)
$1.7m (FY, 2017)
Cost of goods
Cost of goods
$5m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$302 (FY, 2017)
Cost of goods
$1.4m (FY, 2017)
Gross profit
Gross profit
$9.8m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
$7.4k (FY, 2017)
Gross profit
$292k (FY, 2017)
Net income
Net income
($19m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
($7m) (FY, 2017)
Net income
($20.7m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 12.7m (over 3 years ago)
Latest funding round
$ 20m (11 months ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 47.2m
Total funding raised
$ 48.8m
Total funding raised
$ 35.6m
Total funding raised
N/A
Total funding raised
$ 1.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Lineagen
HQ
Salt Lake City, US
Employees
104

Lineagen provides genetic evaluation services in autism, developmental delay and other genetic disorders.

View company
Orig3n
HQ
Boston, US
Employees
52

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

View company
Co-Diagnostics
HQ
Sandy, US
Employees
12

Co-Diagnostics is a molecular diagnostics company with a mathematical approach to DNA test design.

View company
Precipio
HQ
Omaha, US
Employees
19

Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine.

View company